| 英文别名 |
clemastine fumarate;clemastine hydrogen fumarate;Clemastine (fumarate);Meclastine fumarate;(+)-2-[2-[(p-Chloro-α-methyl-α-phenylbenzyl)oxy]ethyl]-1-methylpyrrolidine fumarate salt;Clemastine fumarate salt;Pyrrolidine (2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl;Tavist,Agasten;(2R)-2-[2-[(1R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate salt;1-Methyl-2-[2-(methyl-p-chlorodiphenylmethyloxy)ethyl]pyrrolidine fumarate salt;1-Methyl-2-[2-(α-methyl-p-chlorobenzhydryloxy)ethyl]pyrrolidine fumarate salt;Meclastine fumarate salt;Mecloprodine;(2R)-2-[2-[(1R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine but-2-enedioic acid;hs592;tavist;Alagyl;agasten;lecasol;piloral;reconin;tavegil;tavegyl;trabest;Aloginan;Xolamin;Kinotomin;Inbestan;Fuluminol;Clemanil;Masletine;Lacretin;Anhistan;Alphamin;Marsthine;Maikohis;Mallermin-F;Telgin-G;Tavist-1;Meclastine hydrogen fumarate;Contac 12 Hour Allergy;19259EGQ3D;C21H26ClNO.C4H4O4;(+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alph;HS-592 fumarate;Clemastine fumarate;Topcare dayhist allergy;(R)-2-[2-[(R)-1-(4-Chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine fumarate;CLEMASTINE FUMARATE (EP MONOGRAPH);14976-57-9;Tox21_110574_1;(2R)-2-(2-((1R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine (2E)-but-2-enedioate;AKOS037643271;Pyrrolidine,2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methyl-, (2R)-,(2E)-2-butenedioate (1:1);Clemastine fumarate, European Pharmacopoeia (EP) Reference Standard;AS-12093;Clemastine for system suitability;CLEMASTINE FUMARATE [MART.];NCGC00180903-02;NSC756685;s1847;CLEMASTINE FUMARATE [VANDF];(+)-(2R)-2-(2-(((R)-p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methylpyrrolidine fumarate (1:1);Clemastine for system suitability, European Pharmacopoeia (EP) Reference Standard;Clemastine fumarate, United States Pharmacopeia (USP) Reference Standard;Tox21_110574;CLEMASTINE FUMARATE [USP MONOGRAPH];HMS500O07;HMS1920O13;NCGC00180903-01;TAVIST-D COMPONENT CLEMASTINE FUMARATE;BCP27945;Pyrrolidine, 2-(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methyl-, (R-(R*,R*))-, (E)-2-butenedioate (1:1);CLEMASTINE FUMARATE [EP MONOGRAPH];Prestwick_680;(+)-2-(2-((p-chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl pyrrolidine;(R-(R*,R*))-2-(2-(1-(p-Chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium hydrogen fumarate;Clemastine fumarate [USAN:USP:BAN:JAN];H10994;(2R)-2-(2-((1R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidinium (2E)-3-carboxyprop-2-enoate;CLEMASTINE FUMARATE [HSDB];HMS3884K12;SCHEMBL41468;Q27106180;SW196835-3;CLEMASTINE FUMARATE [USAN];SR-05000001590-1;CLEMASTINE HYDROGEN FUMARATE [MI];(R)-2-(2-((R)-1-(4-chlorophenyl)-1-phenylethoxy)ethyl)-1-methylpyrrolidine fumarate;HMS1568N14;(2R)-2-[2-[(1R)-1-(4-Chlorophenylethoxy]ethyl]-1-methyl-2-pyrrolidine fumarate;Clemastine fumarate... |